Position in ZTS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$25,961,435
-$14,809,547 QoQ
Shares Held
361,278
+4.7% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#141
of 1,412 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026KBC Group NV holds $54,185,094 across 22 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (47.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
361,278 | $25,961,435 | |
| 2 | VTRS |
Viatris Inc
|
656,354 | $10,422,901 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
9,065 | $4,911,688 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
75,831 | $3,111,345 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
17,109 | $2,883,550 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
91,785 | $2,258,828 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
62,171 | $2,106,353 | |
| 8 | LQDA |
Liquidia Corp
|
12,930 | $1,030,908 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,961,435 | 361,278 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $40,770,982 | 344,903 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $49,200,023 | 391,035 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $54,542,388 | 372,761 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $53,105,184 | 340,527 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $52,000,255 | 315,823 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $45,101,629 | 276,816 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $73,300,128 | 375,167 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $62,584,345 | 361,008 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $57,048,642 | 337,147 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $56,083,079 | 284,152 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $96,899,378 | 556,957 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $95,537,629 | 554,774 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $58,198,075 | 349,664 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $45,764,780 | 312,281 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $102,816,574 | 693,348 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $152,990,006 | 890,046 | Shares | Defined | 2024-02-14 | |
| 2022-03-31 | $184,028,762 | 975,814 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $274,617,452 | 1,125,343 | Shares | Defined | 2024-02-14 | |
| 2021-09-30 | $140,619,678 | 724,321 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $117,036,129 | 628,011 | Shares | Defined | 2022-02-15 | |
| 2021-03-31 | $74,150,559 | 470,857 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $65,420,991 | 395,293 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $33,715,470 | 203,879 | Shares | Defined | 2022-02-14 | |
| 2020-06-30 | $32,487,797 | 237,068 | Shares | Defined | 2022-02-14 | |
| 2020-03-31 | $28,118,022 | 238,916 | Shares | Defined | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||